Bivictrix Therapeutics【BVX】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
イギリス
LSE
Bivictrix Therapeutics Plc (BVX) 銘柄情報

Bivictrix Therapeutics Plc (BVX)

10.00

0.00

(0.00%)

終了 11月27日 1:30AM

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

10.00

買値

8.50

売値

9.50

出来高

0.00

0.00 日の範囲 0.00

7.50 52 週間の範囲 13.00

時価総額

前日終値

10.00

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

60,223

発行済株式数

82,526,088

配当利回り

-

PER

-3.25

1 株当たり利益 (EPS)

-0.03

歳入

-

純利益

-2.55M

セクター

Coml Physical, Biologcl Resh

業界

Coml Physical, Biologcl Resh

ウェブサイト

www.bivictrix.com

本社

Manchester, Gbr

設立

-

Bivictrix Therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the ロンドン証券取引所 with ticker BVX. The last closing price for Bivictrix Therapeutics was 10p. Over the last year, Bivictrix Therapeutics shares have traded in a share price range of 7.50p to 13.00p.

Bivictrix Therapeutics currently has 82,526,088 shares in issue. The market capitalisation of Bivictrix Therapeutics is £8.25 million. Bivictrix Therapeutics has a price to earnings ratio (PE ratio) of -3.25.

AIM Cancellation - BiVictriX Therapeutics plc

AIM 11 September 2024 NOTICE 11/09/2024 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM At the request of the Company the following securities have been cancelled from...

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 10 September 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

BiVictriX Therapeutics PLC Last Day of Dealings

BiVictriX Therapeutics PLC 10 September 2024 BiVictriX Therapeutics plc ("BiVictriX", "BiVictriX Therapeutics" or the "Company") Last Day of Dealings Alderley Park, 10 September 2024...

Bivictrix Therapeutics optimistic about BVX002 after in vivo testing

Bivictrix Therapeutics PLC announced on Monday it has received "positive" in vivo test results from its BVX002 solid ...

BiVictriX Therapeutics PLC Positive In Vivo Data from BVX002 Programme

BiVictriX Therapeutics PLC 09 September 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by...

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 02 September 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

BiVictriX Therapeutics PLC Director Dealing

BiVictriX Therapeutics PLC 02 September 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF...

BiVictriX Therapeutics PLC Result of General Meeting

BiVictriX Therapeutics PLC 29 August 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by...

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 28 August 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 28 August 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

AIM Cancellation - BiVictriX Therapeutics plc

AIM 11 September 2024 NOTICE 11/09/2024 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM At the request of the Company the following securities have been cancelled from...

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 10 September 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

BiVictriX Therapeutics PLC Last Day of Dealings

BiVictriX Therapeutics PLC 10 September 2024 BiVictriX Therapeutics plc ("BiVictriX", "BiVictriX Therapeutics" or the "Company") Last Day of Dealings Alderley Park, 10 September 2024...

Bivictrix Therapeutics optimistic about BVX002 after in vivo testing

Bivictrix Therapeutics PLC announced on Monday it has received "positive" in vivo test results from its BVX002 solid ...

BiVictriX Therapeutics PLC Positive In Vivo Data from BVX002 Programme

BiVictriX Therapeutics PLC 09 September 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by...

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 02 September 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

BiVictriX Therapeutics PLC Director Dealing

BiVictriX Therapeutics PLC 02 September 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF...

BiVictriX Therapeutics PLC Result of General Meeting

BiVictriX Therapeutics PLC 29 August 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	10	10	10	0	0	DE
4	0	0	10	10	10	0	0	DE
12	2.5	33.3333333333	7.5	10	7.5	60223	8.75756926	DE
26	-1	-9.09090909091	11	13	7.5	84152	8.58685671	DE
52	-1	-9.09090909091	11	13	7.5	57869	9.15043992	DE
156	-14	-58.3333333333	24	33.5	7.5	48063	17.35097106	DE
260	-12.5	-55.5555555556	22.5	33.5	7.5	60313	18.40131837	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ORCPOracle Power Plc	0.0305p (158.47%)	6.24B
STKStreaksai Plc	0.35p (59.09%)	8.58M
QEDQuadrise Plc	3.62p (57.39%)	94.06M
ENWEnwell Energy Plc	23.00p (46.03%)	160.81k
WEBWebis Holdings Plc	0.125p (38.89%)	9.14M
INXI-nexus Global Plc	1.50p (-52.38%)	7.25M
SFRSeverfield Plc	55.60p (-36.24%)	9.71M
LENDSancus Lending Group Limited	0.30p (-33.33%)	1.23M
TRYBTribe Technology Plc	2.45p (-20.97%)	80k
GWMOGreat Western Mining Corporation Plc	0.0175p (-20.45%)	169.92M
ORCPOracle Power Plc	0.0305p (158.47%)	6.24B
NTVONativo Resources Plc	0.0025p (0.00%)	3.46B
TRPTower Resources Plc	0.0275p (0.00%)	526.88M
CPXCap-xx Limited	0.145p (-13.43%)	499.92M
MSMNMosman Oil And Gas Limited	0.038p (-1.30%)	329.43M

jondoeuk

jondoeuk 5分前

A post on LinkedIn (by Alex Shih-Min Huang who is VP, Head of Cell Therapy at BGNE): 'Though our very first experiment was initiated only 2.5 years ago amidst ongoing laboratory construction and pandemic, fast forward to this day, we have already 1) generated a proprietary, well-characterized GMP gr

gfp927z

gfp927z 5分前

Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Barron's

by Paul R. La Monica

Nov 22, 2024

https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2

dinogreeves

dinogreeves 6分前

Analyst are going to scratch their heads tomorrow if there is no press release based on all the notes fully paid off, upwards of 2 billion dollars, if the numbers were cooked and there was going to be fraud charges against the company, they would have taken the money and ran, but instead they paid i

bluebird50

bluebird50 7分前

Guess crows don't like coffee.... delete this post and Crows...

;-) so we don't witness a murder... a group of crows... Che Che Che

BamaBreeze

BamaBreeze 7分前

Good on you!! Bless us.

ducci1

Pivot Calcs: SPX Pivot--6012----R1--6033----R2--6045----S1--6000----S2--5980-----SPY Pivot--599----R1--601----R2--602----S1--598----S2--596-----VIX Pivot--14.33 !!LOL!!

imnot6

Well, extended duration is their value proposition...

JohnnyHydrogen

JohnnyHydrogen 8分前

AI Czar ?

https://www.axios.com/2024/11/26/trump-ai-czar-role-elon-musk

....

"The office would spur the massive private investment needed to expand the energy supply to keep the U.S. on the cutting edge."

gfp927z

gfp927z 9分前

Bigworld, Here's more info relating to Acurx's recent move to buy some Bitcoin (below). So far that boneheaded decision by Luci has cut Acurx's share price nearly in half -

Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

gfp927z

gfp927z 14分前

Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Barron's

by Paul R. La Monica

Nov 22, 2024

https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2

Mountainman5

Mountainman5 14分前

Red Cat & OPT = WinWin!!!!!!!!!!!!!

BDEZ

Thanks georgie..

$GROO

Never Quit $SANP
Never Quit $SANP $GROO ht

Oleblue

Oleblue 16分前

In this solo lecture, Chris Miller, author of the acclaimed book "Chip War", delves into the intricate world of semiconductors, exploring how microchips have become the cornerstone of global power and economic influence. Miller will provide an analysis of the geopolitical ramifications of semiconduc

JettaR

JettaR 18分前

No one is "rooting" for the stock to go down. Eyes wide open. Eyes wide open. It's right on front of everyone.

lambchops

lambchops 18分前

Peeps ought to gobble up some NFTM shares for gobble-gobble day!

Eat turkey--not lamb-- on Christmas! Yum-yum.

Happy T-bird day. And remember,"Fun. Fun, fun till your daddy takes the T-bird awayNFTM

reaper247

reaper247 20分前

Always good to hear from ya Drugdoctor.

I suspect we have a few people lurking around.

Hope all GVSIers have as safe and happy Thanksgiving.

GLTA, IMO and FWIW.

jondoeuk

jondoeuk 20分前

One for FT819 as well https://www.globenewswire.com/news-release/2024/11/18/2982757/24675/en/Fate-Therapeutics-Presents-6-Month-Follow-up-Data-on-First-Patient-Treated-in-Phase-1-Autoimmunity-Study-with-Fludarabine-free-Conditioning-and-FT819-Off-the-shelf-1XX-CAR-T-cell-P.html

skitahoe

skitahoe 21分前

NWBO is in a similar situation in the EU. I believe that you'll find that the 150 days doesn't begin with submission. No one is absolutely certain, some believed it started with preliminary validation, which occurred roughly a month after submission. Others believed it began with final validation

jjjjjjjj

jjjjjjjj 21分前

Gummies for dummies -- yummies , LMAO burger flipper
Reply privately from blusher.

Keep doing the 2 steps:
1. SET SELL HIGH our shares.
2. SET BUY HIGHssssssss with last minute and price limit.

MJNA is a good company. Best to us longs.

jondoeuk

jondoeuk 21分前

The PR https://www.globenewswire.com/news-release/2024/11/18/2982736/24675/en/Fate-Therapeutics-Highlights-FT522-Off-the-shelf-ADR-armed-CAR-NK-Cell-Product-Candidate-at-2024-ACR-Convergence.html

gfp927z

gfp927z 23分前

Xena, All I said was that a B-12 deficiency might be the cause of your advancing foot numbness. Gadolinium toxicity might have the same effect (?), but logic says to eliminate other obvious possibilities before concluding that it is the gadolinium.

>> given the level of supplementa

jondoeuk

jondoeuk 23分前

They need to pick up the pace of enrolment. If they don't see activity at DL2, I think it could be in trouble.

Plato_

Plato_ 28分前

https://investorshub.advfn.com/uimage/uploads/2024/11/27/hcolltrade-error-314217-the-share-quanitty-is-limited.png
Source: https://www.reddit.com/r/fidelityinvestments/comments/1grxuld/comment/ly9voew

FYI. Found this on a subreddit regarding Fidelity restrictions on trade size.

gimmegimmeminemine

gimmegimmeminemine 29分前

At a bare minimum, I want to see viable proof that they have solved the issue of mass scale production, cost effectively on a quality consistent basis.
Clear and consice viable proof.

I would be ecstatic if they are ready or already putting out product on a regular basis, be i

Bivictrix Therapeutics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約